Dr. Namrata Jayanth is a Research Leader Advanced Modalities at Charles River’s Early Discovery site in Leiden, Netherlands. She has several years of industrial and academic experience in Cancer Cell Biology, In Vitro Pharmacology, and Drug Discovery. Previously at Bristol-Myers Squibb Research Centre, she was a Discovery Biology Team Lead, responsible for early-stage discovery and preclinical progression of small-molecules and therapeutic antibodies for Oncology and Immunology portfolios. During her academic career, she worked as a Post-Doctoral Fellow at the Massachusetts Institute of Technology (MIT), USA, focusing on regulatory proteins and gene editing. Prior to this, she was a joint Post-Doctoral Fellow with the University of Cambridge, UK and InStem, India, studying signaling proteins in cancer pathways. She holds a PhD in Biochemistry and Biophysics from the Tata Institute of Fundamental Research (TIFR), India.
WEBINAR: Antibody Discovery Meets NAMs: Pathways to Faster, Safer Biologics
This webinar challenges conventional thinking and introduces a human-relevant, animal-light approach to antibody development. Discover how new approach methodologies (NAMs), including organoids, primary tissue models, cell microarrays, and AI-powered prediction tools, can transform your discovery to IND continuum to improve translational outcomes. Watch Replay